Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=45

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00143507-80844f9e",
        "title": "Ivabradine vs Placebo: Hospitalisation for Coronary Revascularisation",
        "summary": "155 of 5479 against 186 of 5438; risk difference -0.6 points, 95% interval -1.2 to 0.1; NCT00143507, The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction",
        "record": "/library/comparisons/NCT00143507-80844f9e",
        "nct_id": "NCT00143507",
        "kind": "outcome",
        "participants": 10917,
        "risk_difference": {
          "value": -0.005913917467885839,
          "lower": -0.012493253368131247,
          "upper": 0.0006236505515892611
        },
        "group_1": "155 of 5,479",
        "group_2": "186 of 5,438",
        "difference": "-0.6 points",
        "interval": "-1.2 to 0.1",
        "trial_title": "The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction"
      },
      {
        "id": "NCT00143507-a5482f9f",
        "title": "Ivabradine vs Placebo: Hospitalisation for Unstable Angina",
        "summary": "114 of 5479 against 105 of 5438; risk difference 0.1 points, 95% interval -0.4 to 0.7; NCT00143507, The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction",
        "record": "/library/comparisons/NCT00143507-a5482f9f",
        "nct_id": "NCT00143507",
        "kind": "outcome",
        "participants": 10917,
        "risk_difference": {
          "value": 0.001498147227157274,
          "lower": -0.003797337701753961,
          "upper": 0.0068040231257648735
        },
        "group_1": "114 of 5,479",
        "group_2": "105 of 5,438",
        "difference": "0.1 points",
        "interval": "-0.4 to 0.7",
        "trial_title": "The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=46",
  "request_id": "FOQmfmpud24liC22"
}